In 2017 NCC provided advice to a privately held company, Caelus Health, developing new microbiome-based strategies for disease prevention. We delivered an expert opinion on further steps with a new lead. This project included identifying business scenarios for supplements to consumer markets and potential market entries for EU and USA. Based on a thorough analysis of the scientific and regulatory environments we advised on communication strategies and a storyline for the product(s). A rough valorization of the scenarios was made as well. The whole task was performed in one month in time and in full, using our own expertise and one external professional. The NCC opinion was highly valued by the client. Since then the company moved the product to a Phase 2B clinical trial.